• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Transl Med . T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individual

tetano

Editor, Senior Moderator
Sci Transl Med


. 2021 Mar 15;eabf7517.
doi: 10.1126/scitranslmed.abf7517. Online ahead of print.
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals


Tatjana Bilich[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Annika Nelde[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Jonas S Heitmann[SUP] #[/SUP][SUP] 1 3 [/SUP], Yacine Maringer[SUP] 1 2 3 [/SUP], Malte Roerden[SUP] 2 3 4 [/SUP], Jens Bauer[SUP] 1 2 [/SUP], Jonas Rieth[SUP] 1 2 [/SUP], Marcel Wacker[SUP] 5 [/SUP], Sebastian H?rber[SUP] 5 [/SUP], David Rachfalski[SUP] 1 [/SUP], Melanie M?rklin[SUP] 1 3 [/SUP], Stefan Stevanovi?[SUP] 2 3 6 [/SUP], Hans-Georg Rammensee[SUP] 2 3 6 [/SUP], Helmut R Salih[SUP] 1 3 6 [/SUP], Juliane S Walz[SUP] 7 2 3 8 [/SUP]



Affiliations

Abstract

Long-term immunological memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for the development of population-level immunity, which is the aim of vaccination approaches. Reports on rapidly decreasing antibody titers have led to questions regarding the efficacy of humoral immunity alone. The relevance of T cell memory after coronavirus disease 2019 (COVID-19) remains unclear. Here, we investigated SARS-CoV-2 antibody and T cell responses in matched samples of COVID-19 convalescent individuals up to six months post-infection. Longitudinal analysis revealed decreasing and stable spike- and nucleocapsid-specific antibody responses, respectively. In contrast, functional T cell responses remained robust, and even increased, in both frequency and intensity. Single peptide mapping of T cell diversity over time identified open reading frame-independent, dominant T cell epitopes mediating long-term SARS-CoV-2 T cell responses. Identification of these epitopes may be fundamental for COVID-19 vaccine design.
 
Back
Top Bottom